Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Revenue rose 7% YoY to Rs 3,434 crore in Q2FY25.
EBITDA grew 30.2% YoY to Rs 602 crore, while the EBITDA margins stood at 17.5%.
Shares of Glenmark dropped 0.44% to close at Rs 1531.70 on BSE, the benchmark Sensex declined 0.14% to end at 77,580.31. The results were announced after market hours.
India business grew by 13.9% YoY to Rs. 1282 crore led by continuous improvement in market share across cardiac, dermatology and respiratory therapeutic segments.
Stock Trading
Ichimoku Trading Unlocked: Expert Analysis and Strategy
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
RSI Trading Techniques: Mastering the RSI Indicator
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Dow Theory Made Easy
By — Vishal Mehta, Independent Systematic Trader
Stock Trading
Options Trading Made Easy: Options Trading Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Introduction to Technical Analysis & Candlestick Theory
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Market 103: Mastering Trends with RMI and Techno-Funda Insights
By — Rohit
